CVI Holdings’s Zymeworks ZYME Stock Holding History

CVI Holdings’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-16,956	Closed	-$373K	–	62
2019 Q2	$373K	Buy	+16,956	New	+$311K	0.43%	28

Other funds holding ZYME

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CVI Holdings's ZYME Position: Q3 2019 in Review

CVI Holdings sold out of Zymeworks (ZYME) in Q3 2019, closing a stake of 16,956 shares — an estimated $373K sold.

CVI Holdings first reported a position in ZYME in Q2 2019 and held it in 1 quarter. The position peaked at $373K in Q2 2019. 74 funds tracked by Wall St. Rank hold ZYME as of Q3 2019.

CVI Holdings reported no remaining Zymeworks position as of Q3 2019 after selling out during the quarter.
CVI Holdings sold 16,956 Zymeworks shares in Q3 2019, an estimated $373K.
CVI Holdings first reported a position in Zymeworks in Q2 2019 and held it in 1 quarter.
CVI Holdings's Zymeworks position peaked at $373K in Q2 2019.
74 funds tracked by Wall St. Rank held Zymeworks as of Q3 2019.

Based on CVI Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.